[2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate

C54H75NO14 — CID 90147830

IUPAC[2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate
SMILESCOc1ccc(C(=O)OC2C(OC3C(O)COC(O[C@H]4C[C@H]5[C@@H]6CC=C7C[C@@H](OC(=O)NCc8ccccc8)CC[C@]7(C)C6CC[C@]5(C)[C@@]4(O)[C@H](C)C(=O)CCC(C)C)C3C)OCC(O)C2O)cc1
InChIInChI=1S/C54H75NO14/c1-30(2)13-20-41(56)32(4)54(62)44(67-49-31(3)46(43(58)29-64-49)69-50-47(45(59)42(57)28-65-50)68-48(60)34-14-17-36(63-7)18-15-34)26-40-38-19-16-35-25-37(66-51(61)55-27-33-11-9-8-10-12-33)21-23-52(35,5)39(38)22-24-53(40,54)6/h8-12,14-18,30-32,37-40,42-47,49-50,57-59,62H,13,19-29H2,1-7H3,(H,55,61)/t31?,32-,37+,38-,39?,40+,42?,43?,44+,45?,46?,47?,49?,50?,52+,53+,54-/m1/s1
InChIKeyXBIHBBYHSFFLDH-YOSQBELBSA-N
MW962.19 g/mol
LogP6.66
Rot. Bonds15

About [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate

[2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate (PubChem CID 90147830) has the molecular formula C54H75NO14 and a molecular weight of 962.19 g/mol. Its IUPAC name is [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate.

Molecular Properties

Compound Name[2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate
PubChem CID90147830
Molecular FormulaC54H75NO14
Molecular Weight962.19 g/mol
Exact Mass961.52
IUPAC Name[2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate
SMILESCOc1ccc(C(=O)OC2C(OC3C(O)COC(O[C@H]4C[C@H]5[C@@H]6CC=C7C[C@@H](OC(=O)NCc8ccccc8)CC[C@]7(C)C6CC[C@]5(C)[C@@]4(O)[C@H](C)C(=O)CCC(C)C)C3C)OCC(O)C2O)cc1
InChIInChI=1S/C54H75NO14/c1-30(2)13-20-41(56)32(4)54(62)44(67-49-31(3)46(43(58)29-64-49)69-50-47(45(59)42(57)28-65-50)68-48(60)34-14-17-36(63-7)18-15-34)26-40-38-19-16-35-25-37(66-51(61)55-27-33-11-9-8-10-12-33)21-23-52(35,5)39(38)22-24-53(40,54)6/h8-12,14-18,30-32,37-40,42-47,49-50,57-59,62H,13,19-29H2,1-7H3,(H,55,61)/t31?,32-,37+,38-,39?,40+,42?,43?,44+,45?,46?,47?,49?,50?,52+,53+,54-/m1/s1
InChIKeyXBIHBBYHSFFLDH-YOSQBELBSA-N
XLogP6.66
TPSA208.77 Ų
H-Bond Donors5
H-Bond Acceptors14
Rotatable Bonds15
Heavy Atoms69
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500962.19
LogP ≤ 56.66
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate?
The IUPAC name of [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate (CID 90147830) is [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate.
What is the SMILES notation for [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate?
The canonical SMILES for [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate is COc1ccc(C(=O)OC2C(OC3C(O)COC(O[C@H]4C[C@H]5[C@@H]6CC=C7C[C@@H](OC(=O)NCc8ccccc8)CC[C@]7(C)C6CC[C@]5(C)[C@@]4(O)[C@H](C)C(=O)CCC(C)C)C3C)OCC(O)C2O)cc1.
What is the InChIKey of [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate?
The InChIKey is XBIHBBYHSFFLDH-YOSQBELBSA-N. The full InChI is InChI=1S/C54H75NO14/c1-30(2)13-20-41(56)32(4)54(62)44(67-49-31(3)46(43(58)29-64-49)69-50-47(45(59)42(57)28-65-50)68-48(60)34-14-17-36(63-7)18-15-34)26-40-38-19-16-35-25-37(66-51(61)55-27-33-11-9-8-10-12-33)21-23-52(35,5)39(38)22-24-53(40,54)6/h8-12,14-18,30-32,37-40,42-47,49-50,57-59,62H,13,19-29H2,1-7H3,(H,55,61)/t31?,32-,37+,38-,39?,40+,42?,43?,44+,45?,46?,47?,49?,50?,52+,53+,54-/m1/s1.
What are the key properties of [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate?
[2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate has a molecular weight of 962.19 g/mol, XLogP of 6.66, 15 rotatable bonds, 5 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[2-[[(3S,8R,10R,13S,14S,16S,17S)-3-(benzylcarbamoyloxy)-17-hydroxy-10,13-dimethyl-17-[(2S)-6-methyl-3-oxoheptan-2-yl]-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-16-yl]oxy]-5-hydroxy-3-methyloxan-4-yl]oxy-4,5-dihydroxyoxan-3-yl] 4-methoxybenzoate is sourced from PubChem (CID 90147830), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).